Treatment in Barcelona (Spain)

Radiation oncologist

Oncologist, Specialist in skin cancer treatment

General and digestive tract surgeon with expertise in minimally invasive laparoscopic surgery. Has held Associate Clinical Lecturer and Lecturer positions at the University of Navarre School of Medicine. Member of the Spanish Association of Surgeons, Spanish Society of Obesity Surgery, and European Association for Endoscopic Surgery.

Discovered the genetic cause of a rare syndrome causing sudden heart death called afterward as Brugada Syndrome.
Has performed over 25,000 cardiac ablations.
Has published over 350 scientific papers on cardiology.
Has trained over 200 specialists.
Has annual visits to Africa to treat children with arrhythmia.

Dr. Moises graduated from the Faculty of Medicine of the Universidad Nacional de Tucumán in 1992 with a degree in Medicine and Surgery. He specialized in nephrology and defended his doctoral dissertation in 1995. He also received a research grant from the Universidad Nacional de Tucumán en Médico. He was a specialist in the Transplant Department of Hospital Clínic de Barcelona from 1995 to 2000, and the leading specialist of the Teknon Internal Medicine Department from 2004 to 2009. He is currently the head of this department and is a member of various organizations, including the Spanish Society of Nephrology, Spanish Society of Arterial Hypertension, and Catalan Society of Arterial Hypertension.

Dr. Lana Bijelic is an oncological surgeon and specialist in peritoneal carcinomatosis who joined the Teknon Oncology Institute’s Carcinomatosis Surgical Group in 2019. She is certified by the American Board of Surgery and is a member of various scientific communities, including the American College of Surgeons and the Society of Surgical Oncology. She has held various research and clinical positions, and has been awarded numerous academic achievements.

Dr. Antonio Alcaraz is a Spanish uro-oncologist and transplantologist with over 30 years of experience and 500 successful operations, specializing in the treatment of prostate cancer, kidney, bladder, and other urogenital system pathologies using minimally invasive and robotic systems, as well as congenital pathologies in children. He is a member of several prestigious urological societies.

Children's Hematologist, Head of the Center of Bone Marrow Transplantation

This doctor has experience in endocrine treatment, collaborating on studies aimed at overcoming resistance to hormone therapy. They have also been involved in numerous phase 1, 2 and 3 studies in breast and melanoma, which have led to the approval of new drugs in new indications. Their main area of interest lies in immunotherapy for melanoma treatment and patient care. They have participated in trials that have led to the approval of cdk4/6 palbociclib and ribociclib inhibitors in the first line of metastatic breast cancer, and Pembrolizumab in the first line of metastatic melanoma, as well as the combination of Nivolumab and Ipilimumab. They are a member of the Breast Cancer Unit and Melanoma Unit at the Vall d'Hebron University Hospital and the Vall d'Hebron Institute of Oncology. This doctor is an experienced oncologist with expertise in breast cancer and melanoma treatments, including endocrine therapy, immunotherapy, and patient care. They have been involved in numerous clinical trials leading to the approval of new drugs in new indications.